The Union de pharmacologie scientifique appliquée ( or UPSA for short) was originally a French pharmaceutical group who remained as an independent company from 1935 to 1994. Then towards the end of 1994 they were taken under acquisition by the US pharma company Bristol-Myers Squibb.
UPSA was founded in Agen, Rueil-Malmaison, France in 1935 by Dr Camille Bru. Following the company founder’s death in 1958 the group was then run by his son Jean Bru until he died in 1989, and then by Jean Bru’s widow Nicole Bru, née Magniez, from 1989 up until 1994. The Fondation Bru administers the charitable and cultural interests of the family.
They are a French pharma firm that develop medicines, medical devices, and also food supplements. They focus on severe pain treatment medications as well as nasal and throat sprays, cough and cold medicines, etc. They are a manufacturer of over-the-counter medicine for the use of pain and self-medication. The company specializes in medicines against flu, vitality, digestion and sleep disorder. They provide consumers of all age groups, with drugs, medical devices and food supplements to treat illnesses of everyday life.
You can find on our website UPSA Dafalgan Codeine 30 mg Paracetamol 500 mg, which is an opiate based painkiller treatment used for treating mild to moderate pain and various other pain types. UPSA play a large part in the Pharmaceutical Manufacturing Industry. The company has 1,602 employees and generates $435.98 million in sales (USD). There are 85 companies in the UPSA SAS corporate family.